IP Library Granted Patent US 9,517,293
Granted Patent B2
US 9,517,293 · App. 14/070,122 · Granted Dec 13, 2016

Tricalcium phosphates, their composites, implants incorporating them, and methods for their production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,517,293
App. No.
14/070,122
Granted
Dec 13, 2016
Kind
B2
Abstract

Methods for the synthesis of tricalcium phosphates are presented, as well as a series of specific reaction parameters that can be adjusted to tailor, in specific ways, properties in the tricalcium phosphate precursor precipitate. Particulate tricalcium phosphate compositions having an average crystal size of about 250 nm or less are provided. Compositions of the invention can be used as prosthetic implants and coatings for prosthetic implants.

Claims (17)

1. A method for preparing particulate TCP comprising:

(i) precipitating a TCP precursor from a solution containing a calcium source to a phosphate source, wherein the pH of the mixture is about 5 to about 11,

(ii) aging the precipitated TCP precursor,

(iii) controlling the conditions of steps (i) and (ii) so as to produce a TCP precursor precipitate having an average crystal size of 250 nm or less,

(iv) collecting the TCP precursor precipitate,

(v) drying the TCP precursor,

(vi) milling the TCP precursor, and

(vii) calcining the TCP precursor to obtain a particulate TCP having an average crystal size of 250 nm or less, a surface area of about 20 m 2 /g and particle size of 5 μm or less.

2. The method of claim 1 , wherein step (i) involves adding the calcium source to the phosphate source.

3. The method of claim 1 , wherein the calcium source is calcium nitrate and the phosphorus source is selected from the group consisting of ammonium phosphate, ammonium hydrogen phosphate, ammonium dihydrogen phosphate, or a combination thereof.

4. The method of claim 1 , wherein the calcium source and phosphate source has an atomic ratio (Ca/P) of about 1.4 to about 1.6.

5. The method of claim 1 , wherein the mixture has a pH of between about 7 and about 10.

6. The method of claim 1 , wherein the precipitated apatite is aged at a temperature of about 0° C. to about 90° C.

7. The method of claim 1 , wherein the precipitated apatite is aged at a temperature of about 10° C. to about 30° C.

8. The method of claim 1 , wherein the precipitated apatite is aged for at least 2 hours.

9. The method of claim 1 , wherein the precipitated TCP precursor is further calcined at a temperature of about 1000° C. to about 1400° C.

10. The method of claim 1 , wherein the precipitated TCP precursor is further calcined at a temperature of about 400° C. to about 900° C.

Assignments (10)
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068539/0492 →
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 068539/0665 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Dec 22, 2023
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066095/0635 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Dec 22, 2023
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066095/0652 →
MERGER Recorded Oct 19, 2023
From: PIONEER SURGICAL TECHNOLOGY, INC.
To: PIONEER SURGICAL TECHNOLOGY NEWCO, INC.
Reel/Frame 065287/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2023
From: PIONEER SURGICAL TECHNOLOGY NEWCO, INC.
To: XTANT MEDICAL HOLDINGS, INC.
Reel/Frame 065218/0590 →
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →